Microbot Medical Inc. in a continuation of its efforts to create barriers and expand its global intellectual property portfolio for the LIBERTY® Robotic System, was issued a design patent allowance by the US Patent & Trademark Office (USPTO), covering the LIBERTY Robotic System's remote controller unique interface design. The Company will be showcasing and demonstrating the LIBERTY Robotic System on January 9-11, 2023, in San Francisco, CA, concurrent with a leading healthcare conference.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | -1.11% | -17.59% | -45.73% |
Apr. 16 | HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating | MT |
Mar. 27 | Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.73% | 12.82M | |
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- MBOT Stock
- News Microbot Medical Inc.
- Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance